A community pharmacy approach to identifying colorectal cancer risk factors
Active Project Grant Awarded Last action
- Award ID
- HT9425261E398
- Recipient
-
Missouri Pharmaceutical Association UEI NJMLP91JQA81
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $4,200,000
Award facts
- Assistance listing
- 12.420 Military Medical Research and Development
- Completion date 5% complete
- Place of performance
- Jefferson City, MO, USA
Award details come from USAspending.gov.
About this award
The Defense Health Agency awarded the Missouri Pharmaceutical Association $4.2 million on August 1, 2026, under the Military Medical Research and Development program (CFDA 12.420) to develop a community pharmacy approach to identifying colorectal cancer risk factors. Performance occurs in Jefferson City, Missouri, with completion targeted for July 31, 2030. The award is structured as a Project Grant, with $4.2 million obligated at issuance.
Quick answers
Who received award HT9425261E398?
HT9425261E398 was awarded to Missouri Pharmaceutical Association by Defense Health Agency (Department of Defense) on August 1, 2026.
How much is award HT9425261E398 worth?
$4,200,000 has been obligated on HT9425261E398.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award